Dasatinib Metabolite F-d8 |
|
Synonyms: N-Deshydroxyethyl Dasatinib-d8; N-(2-Chloro-6-methylphenyl)-2-[[2-methyl-6-(1-piperazinyl-d8)-4-pyrimidinyl]amino]-5-thiazolecarboxamide; Dasatinib Metabolite M4-d8; | |
Cat. No.: D25052 | CAS No.: 1189998-96-6 /910297-51-7(unlabelled) |
MDL.: | Formula: C20H14D8ClN7OS |
F.W.452 | Purity: 99% |
Storage: Refrigerator | |
  |

Catalog Number: | D25052 | CAS No.: | 1189998-96-6 /910297-51-7(unlabelled) | |
MDL: | Formula: | C20H14D8ClN7OS | ||
F.W.: | 452 | Purity: | 99% | |
Package: | Unit: | mg | ||
Appearance: | Off-White Solid | M.P.: | >280°C (dec.) | |
B.P.: | Density: | |||
Optical Rotation: | Refractive Index: | |||
Solubility: | DMSO, Methanol | Stability: | ||
Storage: | Refrigerator | Category: | Reference Standard | |
Reference: | Trentham, D., et al.: Biochem. J., 126, 635 (1972), Matsuguchi, T., et al.: J. Biol. Chem., 269, 5016 (1994), Berman, E., et al.: Leukemia Res., 24, 289 (2000), Tokarski, J., et al.: Cancer Res., 2006, 66, 5790 (2006), | |||
Application: | A labelled metabolite of Dasatinib. Used in the treatment of cancers and immune diseases. | |||
Category: | Isotope Labelled Compounds, Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals, |